Glycogen storage disease
Pathogenesis of Hepatic Tumors following Gene Therapy in Murine and Canine Models of Glycogen Storage Disease
10
Lessons from new mouse models of glycogen storage disease type 1a in relation to the time course and organ specificity of the disease
23
Clinical and biochemical heterogeneity between patients with glycogen storage disease type IA: the added value of CUSUM for metabolic control
9
Hepatic lentiviral gene transfer prevents the long-term onset of hepatic tumours of glycogen storage disease type 1a in mice
32
G6PC mRNA Therapy Positively Regulates Fasting Blood Glucose and Decreases Liver Abnormalities in a Mouse Model of Glycogen Storage Disease 1a
9
en fr Characterization of a new mouse model of glycogen storage disease type 1a : from glucose homeostasis to gene therapy Caractérisation d’un nouveau modèle murin de glycogénose de type 1a : du métabolisme glucidique à la thérapie génique
174
FoxO3a overexpression prevents both glycogen overload and autophagic buildup in skeletal muscle of Pompe disease
2
FoxO3a overexpression prevents both glycogen overload and autophagic buildup in Pompe disease
2
Multiscale time-resolved fluorescence study of a glycogen phosphorylase inhibitor combined with quantum chemistry calculations
13
Ollier disease.
7
Chit-based Remote Storage
6
Cryptographic cloud storage framework
59
Food Storage in Permafrost
7
Dependability in cloud storage
131
Dihydrogen Storage and distribution
38
Babel Storage: Uncoordinated Content Delivery from Multiple Coded Storage Systems
7
Strategic developments in collection storage
1
[Wilson's disease]
19
Distribution and storage in networks
194
Model-Driven Cloud Data Storage
6